\BOOKMARK [1][-]{section.1}{Executive summary}{}% 1
\BOOKMARK [1][-]{section.2}{Introduction}{}% 2
\BOOKMARK [1][-]{section.3}{Key products}{}% 3
\BOOKMARK [1][-]{section.4}{Multi-omics integration}{}% 4
\BOOKMARK [1][-]{section.5}{Project management}{}% 5
\BOOKMARK [1][-]{section.6}{Data flow}{}% 6
\BOOKMARK [1][-]{section.7}{Clinical implementation and future prospects}{}% 7
\BOOKMARK [1][-]{section.8}{Strategic collaborations}{}% 8
\BOOKMARK [1][-]{section.9}{Funding model and sustainability}{}% 9
\BOOKMARK [1][-]{section.10}{Key performance indicators}{}% 10
\BOOKMARK [1][-]{section.11}{Single-source management in precision medicine}{}% 11
\BOOKMARK [1][-]{section.12}{In Vitro Diagnostic Medical Devices Regulation \(IVDR\) compliance documentation and version controls}{}% 12
\BOOKMARK [1][-]{section.13}{Future directions and innovation}{}% 13
\BOOKMARK [1][-]{section.14}{Future products}{}% 14
\BOOKMARK [1][-]{section.15}{Benefit analysis}{}% 15
\BOOKMARK [1][-]{section.16}{Intellectual property}{}% 16
\BOOKMARK [1][-]{section.17}{Conclusion}{}% 17
\BOOKMARK [1][-]{section.18}{Abbreviations}{}% 18
